Other At-Risk Groups GLP-1 medications are generally not suitable for individuals with severe gastrointestinal disorders like gastroparesis, those with type 1 diabetes (as these drugs are approved only for type 2 diabetes and obesity), and people with a history of suicidal thoughts, active eating disorders, or heavy alcohol use
If you see advertisements for generic semaglutide, they are usually referring to compounded products, not a true generic medication
Based on the SURMOUNT-1 clinical trial results, Zepbound will likely become the most effective weight loss drug available
the patients lose about 10% of their body weight over the same duration
Zinc status in athletes: relation to diet and exercise
Clear expectations from day one lead to better outcomes